CalAIM 1115 演示評估
返回 CalAIM 1115 演示和 1915b 豁免主頁
As required by the CalAIM 1115 Demonstration’s Special Terms and Conditions, the State must submit evaluation reports to the Centers for Medicare and Medicaid Services (CMS) to determine and analyze the impacts of several demonstration programs over the course of the demonstration period. If you have any questions or concerns, please contact 1115Waiver@dhcs.ca.gov.
On June 27, 2022, DHCS submitted the Draft Evaluation Design for Providing Access and Transforming Health (PATH) Initiative, Global Payment Program (GPP), and Dually Eligible Beneficiary Satisfaction in the Medi-Cal Matching Process.
On December 5, 2022, DHCS received CMS comments on the Draft Evaluation Design. The due date for the PATH/GPP/Duals Evaluation Design has been formally extended by CMS to January 25, 2024.
2 月,,7 2024DHCS 提交了一份經修訂的 評估設計草案 和 信件，其中包含對 CMS 125 月,2022 有關 PATH/GPP/Duals 和 Reentry Demonstration 問題的回應 。
8 月4,2025, DHCS 提交了經修訂的社區支援評估設計。
2月28 、 2025 ，DHCS提交了PATH、GPP、雙重資格、重新入院項目的修訂評估設計方案以及管理式醫療計劃示範項目的草案，同時還提交了DHCS和評估團隊對CMS 6月5 、 2024日意見的回應。
11 月7日， 2025 ，DHCS 獲得了CMS 對 CS、PATH、GPP、雙重資格、重新入院和管理式醫療計劃示範項目的評估設計的批准。
12 月29,2025, DHCS 向 CMS 提交了以下 CalAIM 中期評估報告文件草案：
COVID-19 Public Health Emergency – Managed Care Risk Mitigation Strategies
藥物加州醫療補助健康保健計劃有組織的交付系統（DMC-ODS）
Additional information about the DMC-ODS Evaluation is available on the UCLA ISAP webpage.